With a capital injection of roughly USD 140 million, Alentis Therapeutics can begin scientific trials with two most cancers candidates.
发布者:BY ALBERT RONNING-ANDERSSON,转转请注明出处:https://robotalks.cn/novo-holdings-expands-stake-in-alentis-therapeutics-as-part-of-new-major-investment/